NCT05635903View on ClinicalTrials.gov

Jet or Vibrating Mesh Nebulisation for Secretion Management in ICU

NAUnknownINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

December 22, 2019

Primary Completion Date

December 22, 2023

Study Completion Date

December 22, 2023

Conditions
Respiratory FailureCritical Illness
Interventions
PROCEDURE

Continuous nebulisation 0.9% saline Aerogen Solo vibrating mesh Nebuliser

Continuous nebulisation of 0.9% saline using the Aerogen Solo vibrating mesh nebuliser

PROCEDURE

Intermittent nebulisation 0.9% saline Aerogen vibrating mesh Solo Nebuliser

Intermittent nebulisation of 0.9% saline using the Aerogen Solo vibrating mesh nebuliser

PROCEDURE

Intermittent standard intermittent nebulisation of 0.9% saline Intersurgical Cirrus 2 self sealing Jet Nebuliser

standard intermittent nebulisation of 0.9% saline using the Intersurgical Cirrus 2 self-sealing Jet Nebuliser

Trial Locations (1)

Unknown

RECRUITING

Queen Elizabeth University Hospital, Glasgow

Sponsors

Collaborators (1)

Aerogen
All Listed Sponsors
collaborator

Aerogen

INDUSTRY

lead

NHS Greater Glasgow and Clyde

OTHER

NCT05635903 - Jet or Vibrating Mesh Nebulisation for Secretion Management in ICU | Biotech Hunter | Biotech Hunter